This occurred in patients with both curable and metastatic cancer.
Read moreGuide to Psilocybin
Included is information on the therapeutic timeline, common effects, psilocybin-assisted therapy study designs, clinical trial findings, and participant reports.
To Trip or Not to Trip?
Inside the scientific debate that’s shaping the future of psychedelic therapy: To trip or not to trip?
Can the magic be removed from the mushroom — and should it?
Read moreGlobal Survey 2020 Results: Self-Treatment of LSD and Psilocybin
Positive changes were observed across all 17 outcome items, with the strongest benefits on items related to insight and mood. Negative effects were reported by 22.5% of respondents.
High intensity of psychedelic experience, seeking advice before treatment, treating with psilocybin mushrooms and treating post-traumatic stress disorder were associated with higher scores on the self-treatment outcome scale after averaging values across all 17 items.
Younger age, high intensity of experience and treating with LSD were associated with increased number of negative outcomes.
Read morePsychedelics And Paralysis
Incredible story of Jim Harris, who become paralyzed from the chest down. The mountain athlete found an unlikely ally in recovery: psychedelics.
Read morePsilocybin and Antidepressants
New research suggests that antidepressants can diminish the effects of psilocybin.
Read moreRecent Research on Psilocybin Gives Mixed Results
Compass Pathways published the long awaited results of its phase 2 clinical trial for the treatment of depression with psilocybin–assisted psychotherapy in the New England Journal of Medicine.
Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks.
Read morePsychedelics and the Brain
Microdosing- Panacea or Placebo?
Is it all hype or is there genuine hope for therapeutic application of microdosing?
There’s certainly plenty of ‘conflicting’ information or results available from studies of different methodologies. Here, we begin with an overview of what microdosing is, who does it, and for what purposes. We then review available evidence and summarize benefits and risks of microdosing. Finally, we get more practical and discuss microdosing regimens, measurement of accurate dosing, and ‘set and setting’ consideration to microdosing.
from Ben Malcolm, Spirit Pharmacist
Psilocybin for Alcohol Addiction
In a study published Wednesday in JAMA Psychiatry, scientists found that patients taking this drug, called psilocybin, had an 83 percent decline in heavy drinking, while those who took a placebo experienced a 51 percent decline.
Read morePsychedelics for Depression
Here’s the latest on how psychedelics may help treat depression.
Read more